HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of toltrazuril and clazuril against experimental infections with Eimeria labbeana and E. columbarum in racing pigeons.

Abstract
The efficacy of toltrazuril in comparison with clazuril on heavy experimental Eimeria labbeana and E. columbarum infections in pigeons was investigated. The minimum required dose of toltrazuril to completely suppress oocyst excretion is 20 mg/kg body weight for 1 day. After treatment with toltrazuril, there was a dose-dependent period during which pigeons remained negative; at a dosage of 35 mg/kg or higher, this period was at least 4 weeks. Clazuril at the recommended dose of 2.5 mg/pigeon resulted in a rapid suppression of oocyst excretion, but oocysts were again observed in the feces 20 days after treatment. The fact that oocysts appeared again in the feces 3 to 5 weeks after treatment can probably be explained only by a persistence of endogenous stages, which are not affected during treatment, rather than by a reinfection. Reinfection of the previously medicated and infected pigeons 30 days after the first infection provided some data on possible induced immunity.
AuthorsJ Vercruysse
JournalAvian diseases (Avian Dis) 1990 Jan-Mar Vol. 34 Issue 1 Pg. 73-9 ISSN: 0005-2086 [Print] United States
PMID2322230 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acetonitriles
  • Coccidiostats
  • Triazines
  • clazuril
  • toltrazuril
Topics
  • Acetonitriles (therapeutic use)
  • Animals
  • Bird Diseases (drug therapy)
  • Coccidiosis (drug therapy, veterinary)
  • Coccidiostats (therapeutic use)
  • Columbidae
  • Dose-Response Relationship, Drug
  • Feces (parasitology)
  • Triazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: